Review
Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families [Internet]
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2018.
- PMID: 30566313
- Bookshelf ID: NBK535268
Item in Clipboard
Review
Medications for Opioid Use Disorder: For Healthcare and Addiction Professionals, Policymakers, Patients, and Families [Internet]
Excerpt
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.
Sections
- Executive Summary
- Part 1. Introduction to Medications for Opioid Use Disorder Treatment
- Part 2. Addressing Opioid Use Disorder in General Medical Settings
-
Part 3. Pharmacotherapy for Opioid Use Disorder
- Chapter 3A: Overview of Pharmacotherapy for Opioid Use Disorder
- Chapter 3B: Methadone
- Chapter 3C: Naltrexone
- Chapter 3D: Buprenorphine
- Chapter 3E: Medical Management Strategies for Patients Taking OUD Medications in Office-Based Settings
- Chapter 3F: Medical Management of Patients Taking OUD Medications in Hospital Settings
- Part 4. Partnering Addiction Treatment Counselors With Clients and Healthcare Professionals
- Part 5. Resources Related to Medications for Opioid Use Disorder